


GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer

Nosopharm and Evotec enter into collaboration toaccelerate development of novel antibiotics

Oncovita signs exclusive licensing agreement with Institut Pasteur

Domain Therapeutics strengthens its scientific advisory board with leading GPCR and disease experts

Axovant and Yposkesi sign strategic gene therapy development and manufacturing partnership

Imcyse secures total of €35M in Series B financing round and additional grants

Domain Therapeutics appoints Sylvie Ryckebusch to board of directors

Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology
